VSCI News Alert Vision-Sciences (VSCI) 0.76 12/25/2014 14:56

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vision-Sciences (VSCI) 0.76 $VSCI

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc.
Business Wire - Wed Dec 24, 11:19AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company" (NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

UROPLASTY, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Vision-Sciences, Inc.
Business Wire - Tue Dec 23, 10:40AM CST
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Uroplasty, Inc. ("Uroplasty" (NASDAQ: UPI) concerning the sale to Vision-Sciences, Inc. (NasdaqCM: VSCI). Under the terms of the agreement, Uroplasty shareholders will receive 3.6331 shares of VSCI for each share owned. Based on the closing price of both stocks before the deal was announced, the consideration is valued at approximately $3.67, which is only a 15.6% premium and significantly lower than the 52-week high. Also, at least one analyst estimated a value of $6.00 per share.
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc. -- UPI
PR Newswire - Tue Dec 23, 10:22AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company" (NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 11:50AM CST

ADXS: 7.57 (+0.50), SANW: 3.98 (-0.02), ASPS: 33.81 (+4.37), OCN: 14.88 (-0.14), ZAZA: 3.20 (+0.70), SGOC: 0.61 (-0.02), AAMC: 335.99 (-4.00), VOC: 5.60 (-0.09), TECU: 3.59 (-0.14), RDUS: 37.17 (+0.11), IRMD: 12.64 (+0.14), SKYS: 11.05 (-0.95), VSCI: 0.76 (-0.07), CALA: 22.33 (+1.16), REXX: 5.17 (-0.17), CFRX: 3.99 (+0.10), TRXC: 2.79 (+0.03), CHNR: 1.92 (-0.15), CNET: 1.28 (-0.11), DRYS: 1.20 (-0.04)

UROPLASTY, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Mon Dec 22, 11:42AM CST
Rigrodsky & Long, P.A.:
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc.
Business Wire - Mon Dec 22, 9:42AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company" (NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 8:17AM CST

OCN: 14.88 (-0.14), SGOC: 0.61 (-0.02), NVGN: 2.40 (-0.09), EXAS: 27.60 (+0.39), TGE: 2.11 (+0.15), CZR: 15.44 (+0.20), ENTA: 49.04 (+0.06), NQ: 4.32 (-0.36), PVG: 5.07 (+0.14), RDUS: 37.17 (+0.11), CANF: 3.70 (+0.01), NG: 2.82 (+0.10), SYN: 1.46 (-0.07), GILD: 91.29 (+1.84), VSCI: 0.76 (-0.07), CNET: 1.28 (-0.11), SVM: 1.25 (+0.09)

Uroplasty and Vision-Sciences to Merge, Creating Innovative Medical Device Company Positioned for Growth
GlobeNewswire - Mon Dec 22, 6:00AM CST
All-Stock Combination Creates New Company with Expanded Product Offerings in Urology
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

Uroplasty and Vision-Sciences to Merge, Creating Medical Device Company Positioned for Growth
PR Newswire - Mon Dec 22, 6:00AM CST
Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) entered into a definitive merger agreement under which the two companies will combine in an all-stock transaction to create a new company expected to generate revenue of approximately $50 million for the fiscal year beginning April 1, 2015.
VSCI: 0.76 (-0.07), UPI: 2.30 (unch)

GERD Awareness Week Puts the Focus on Patient-Centric Diagnostics
GlobeNewswire - Tue Nov 25, 7:52AM CST
The 16th Annual GERD Awareness Week, November 23rd-29th is dedicated to heightening awareness of Gastroesophageal Reflux Disease, or GERD, and encouraging people experiencing GERD-related symptoms to consult their physicians. The week emphasizes educating people on common and uncommon symptoms of GERD and what treatment options they may have when consulting with physicians.
VSCI: 0.76 (-0.07)

Vision-Sciences' (VSCI) CEO Howard Zauberman on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 9:55AM CST

VSCI: 0.76 (-0.07)

Vision-Sciences FQ2 EPS of -$0.03
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:38PM CST

VSCI: 0.76 (-0.07)

Vision-Sciences Reports Financial Results of Second Quarter and First Half Fiscal 2015
GlobeNewswire - Wed Nov 05, 3:37PM CST
Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath technology, today announced financial results for the second quarter and first six months of fiscal (FY) 2015, ended September 30, 2014. Highlights include:
VSCI: 0.76 (-0.07)

Study Reveals Endoscopes May Be Susceptible to Inadequate Sterilization Despite Following Reprocessing Guidelines
GlobeNewswire - Tue Nov 04, 1:44PM CST
A new study published in the Journal of the American Medical Association ("JAMA" (Volume 312, issue No. 14) focused on an endoscopic outbreak that included bacteria transmission of New Delhi metallo-β-lactamase (NDM)-producing Escherichia coli, via endoscope to nine patients at a hospital in Illinois. The research study concluded that bacterial contamination "appeared to persist despite the absence of recognized reprocessing lapses." The study's conclusion strongly suggested that facilities should be aware of the potential for transmission of bacteria, including antimicrobial-resistant organisms, via duodenoscopy.
VSCI: 0.76 (-0.07)

Vision-Sciences to Host Second Quarter Fiscal 2015 Results Call
GlobeNewswire - Wed Oct 29, 4:29PM CDT
Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company will release its financial results for the second quarter fiscal 2015, ended September 30, 2014, after the market closes on Wednesday, November 5, 2014. Howard Zauberman, President and Chief Executive Officer, and Gary Siegel, Vice President, Finance, will host a conference call to discuss the results as follows:
VSCI: 0.76 (-0.07)

Vision-Sciences TNE System Offers Solution for Sedation Concerns
GlobeNewswire - Mon Oct 27, 7:00AM CDT
A Simple Procedure and Novel Technology Provide an Alternative to Sedated Esophageal Exams
VSCI: 0.76 (-0.07)

Vision-Sciences Announces CE Mark and European Launch of Next Generation EndoSheath(R) Bronchoscopy System
GlobeNewswire - Wed Oct 01, 9:21AM CDT
Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath technology, today announced the CE Mark approval and European launch of the company's next generation video bronchoscope and EndoSheath technology. The new BRS-5100 video bronchoscope was introduced at the annual ERS (European Respiratory Society) Meeting in Munich, Germany on September 7-10, 2014.
VSCI: 0.76 (-0.07)

Vision-Sciences Introduces Smallest Diameter Flexible Video Laryngoscope to the Ear-Nose-and Throat Market
GlobeNewswire - Mon Sep 22, 7:07AM CDT
The ENT-7000 Offers High Resolution Imaging and Maximum Patient Comfort for Ear Nose and Throat Diagnostics
VSCI: 0.76 (-0.07)

Vision-Sciences Reports First Quarter Fiscal 2015 Results
GlobeNewswire - Mon Aug 04, 3:30PM CDT
Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath technology, today announced financial results for the first quarter of fiscal 2015, ended June 30, 2014.
VSCI: 0.76 (-0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Texas Plumbing Award Signals Local Service Discipline

Updated Category News Views 67

A clogged main line is not glamorous, but it is where a local service reputation gets tested for real. Neighborhood Plumbing and Drain has been named a 2026 Best of Texas Award winner in the Plumbing Contractors category, a recognition that matters less as a trophy than as a public signal: customers around Central Texas have noticed the outfit. For anyone watching the...

Continue Reading
NextPlat’s 150-Patient Test Has a Long Road Ahead

Updated Category News Views 114

A strip of pills can look mundane, yet it is where this entire NextPlat pitch either earns its keep or falls apart. PharmcoRx has signed a partner pharmacy agreement with MedSure Systems for a 150-patient Medicare medication-adherence pilot in South Florida. That is a small starting line, no two ways around it. Still, the mechanics are more interesting than another vague...

Continue Reading
Eight O'Clock Adds Blonde Roast Pods to Its Lineup

Updated Category News Views 149

A lighter cup of coffee just became Eight O'Clock Coffee's newest swing at the single-serve shelf. On Nov. 19, 2026, the company said it introduced Blonde Roast K-Cup pods, a bright and smooth option aimed at drinkers who prefer a lighter roast. The product is available through Keurig.com and Amazon. That is the whole announcement, and frankly it is better to keep it that...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
HLRBO's Data-Heavy Rebuild Changes Hunting Lease Market

Updated Category News Views 149

A hunting lease used to begin with hearsay, blurry photos, and a whole lot of hoping. HLRBO is trying to drag that stubbornly analog process into a data-rich, phone-first marketplace, and frankly, it is about time. The company rebuilt its web and mobile platforms around parcel information, plain-language AI search, mobile lease completion, and its Land IQ™ scoring...

Continue Reading
PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 110

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 156

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 31

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Health In Tech Gets a Real Distribution Test in 2027

Updated Category News Views 190

A 100,000-employee funnel is the sort of number that makes a small InsurTech investor sit up, then reach for the fine print. Health In Tech has brought a national third-party administrator onto its eDIYBS platform, giving the company access to a TPA serving more than 650 employers in over 40 states, with more than 100,000 covered employees as of May 2026. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

Hexagon Agility Nets Record $100M Order from Certarus

Updated Category News Views 79

Hexagon Agility and Certarus: A Major Deal Secured There ain't nothing like landing a big fish in the business world, and Hexagon Agility just hooked a whopper. This major player in clean fuel solutions secured an order from Certarus worth a hefty $100 million. For those who keep tabs, that's Hexagon's largest order for Mobile Pipeline® modules to date, and it's all...

Continue Reading
Performance Food Group Co's Earnings: What to Expect

Updated Category News Views 111

Preparing for Performance Food Group Co's Earnings Report Performance Food Group Co PFGC is on the verge of releasing its latest quarterly earnings report. Investors are keen to know what to anticipate ahead of this significant announcement. Expectations for Earnings Performance Analysts anticipate that Performance Food Group Co will report an earnings per share (EPS) of...

Continue Reading
Innovative Collaboration Transforms Healthcare for Incarcerated Patients

Updated Category News Views 360

Innovative Partnership Shaping Correctional Healthcare Armor Health is embarking on a transformative journey in correctional healthcare through an exciting partnership with Antidote-AI, set to significantly enhance the services provided to incarcerated individuals. This collaboration brings advanced artificial intelligence (AI) capabilities to the forefront of a critical...

Continue Reading
Celebrating Innovation: A Journey Through 17 Years of Left Field Labs

Updated Category News Views 405

Left Field Labs Marks 17 Years of Innovation and Growth Left Field Labs, a creative technology agency within Stagwell (NASDAQ: STGW), celebrates its 17th anniversary with impressive revenue growth and a diverse global client base. This celebration highlights its commitment to delivering transformative digital experiences using advanced AI technologies. Transformative...

Continue Reading
Leadership Changes at Humphreys Capital Pave New Pathway

Updated Category News Views 465

Humphreys Capital's Leadership Transition Overview Humphreys Capital, a prominent institutional investment manager, has announced significant changes in its leadership team. This transition includes the appointment of Grant Humphreys as Chairman of the Board of Directors, succeeding his father, Kirk Humphreys, who will continue his involvement as Chairman Emeritus. Blair...

Continue Reading